干扰素调节因子1缺乏 通过IGFBP7/IGF1R通路改善出血性冲击诱导的损伤
Jimin Cai1, Jiacheng Zhang1, Nan Wang1
1Department of Emergency and Critical Care Medicine, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, People's Republic of China.
The Journal of surgical research
|October 15, 2025
概括
干扰素调节因子1 (IRF1) 缺陷可以防止出血性休克 (HS) 引起的损伤. 这种保护涉及通过胰岛素样生长因子结合蛋白7 (IGFBP7) /IGF1R通路减轻巨细胞灭和炎症.
科学领域:
- 脏生理学和病理学
- 免疫学和炎症的研究
- 细胞损伤的分子机制
背景情况:
- 出血性休克 (HS) 导致大量的血液流失,导致器官功能障碍,特别是脏损伤.
- 之前的研究表明,干扰素调节因子1 (IRF1) 缺乏提供保护,防止脏恶化.
- 本研究研究了IRF1在HS引起的损伤中的作用及其潜在机制.
研究的目的:
- 为了研究IRF1在出血性休克 (HS) 引起的损伤中的作用.
- 阐明IRF1影响HS诱导的损伤的分子机制.
- 为了确定巨细胞灭和IGFBP7/IGF1R通路在IRF1-介导保护中的参与.
主要方法:
- 建立了使用lentivirus的IRF1敲击的出血性休克 (HS) 鼠标模型.
- 在体外产生人类单细胞衍生的巨细胞和诱导的火灭菌.
- 利用双露西法酶记者测定,共免疫沉和西部斑点来分析分子相互作用和基因表达.
- 进行了IGFBP7过度表达的功能救援实验.
主要成果:
- 在HS诱导的老鼠脏中,IRF1被上调;IRF1缺乏缓解了损伤,炎症和热.
- IRF1直接结合并增强了胰岛素样生长因子结合蛋白7 (IGFBP7) 的转录.
- 抑制IRF1降低了IGFBP7的表达,增加了IGF1R的酸化,而IGFBP7的过度表达逆转了IRF1缺乏的保护作用.
结论:
- 缺少IRF1减轻了巨细胞的灭,并保护了HS诱导的损伤.
- 这种保护机制涉及IGFBP7/IGF1R信号通路.
- 向IRF1可能为HS相关的损伤提供治疗策略.
相关概念视频
01:29Acute Kidney Injury II: Pathophysiology
890
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
890
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:22Acute Kidney Injury I: Introduction
572
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
572
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
01:29Acute Kidney Injury III: Clinical Manifestations
817
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
817